Reasons for not receiving interventional therapy in patients with severe emphysema

M. Polke (Germany), M. Roetting (Heidelberg, Germany), N. Sarmand (Heidelberg, Germany), R. Eberhardt (Heidelberg, Germany), F. Herth (Heidelberg, Germany), D. Gompelmann (Heidelberg, Germany)

Source: International Congress 2018 – Endoscopic lung volume reduction
Session: Endoscopic lung volume reduction
Session type: Poster Discussion
Number: 5405
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Polke (Germany), M. Roetting (Heidelberg, Germany), N. Sarmand (Heidelberg, Germany), R. Eberhardt (Heidelberg, Germany), F. Herth (Heidelberg, Germany), D. Gompelmann (Heidelberg, Germany). Reasons for not receiving interventional therapy in patients with severe emphysema. 5405

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Our clinical experience in surgical therapy of patients with bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 344s
Year: 2002

Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations
Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019
Year: 2019



Which severe COVID-19 patients may benefit the most from pulmonary rehabilitation?
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021



Two therapy option in patients with uncontrolled asthma
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

The evaluation of 287 patients with bronchiectasis who had surgical therapy
Source: Annual Congress 2010 - Infections and pleural problems
Year: 2010

Utility of palliative treatment of dyspnoea with epidural methadone in patients with advanced emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 58s
Year: 2001

Clinical experience in surgical therapy of 184 patients with bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 626s
Year: 2004

The evaluation of 239 patients with bronchiectasis who had surgical therapy
Source: Annual Congress 2006 - Surgery for chronic benign disease and management of complications
Year: 2006


A digital therapy for proactively managing exacerbations and delivering therapeutic benefit to patients with moderate to severe asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019

Life-sustaining treatment preferences of patients with severe COPD
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010


Clinical experience in surgical therapy of 257 patients with bronchiectasis
Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology
Year: 2007


Combined immunosuppressive therapy including anti-TNFα in a treatment of severe paediatric sarcoidosis – a case report
Source: Eur Respir J 2006; 28: Suppl. 50, 829s
Year: 2006

Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures
Source: Eur Respir Rev, 26 (145) 170020; 10.1183/16000617.0020-2017
Year: 2017



Symptomatic burden of COPD for patients receiving dual or triple therapy
Source: International Congress 2017 – Management of COPD
Year: 2017


Comparison of the effectiveness of two schedules of pulmonary rehabilitation in patients with severe COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 555s
Year: 2006

Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002

Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease
Source: Annual Congress 2004 - Treatment of pulmonary hypertension
Year: 2004


Survival after endoscopic valve therapy in patients with severe emphysema
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016

Identifying patients with severe asthma that will be benefit from biological therapy
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020